Carson Wealth (CWM LLC)
SLNO

Carson Wealth (CWM LLC)’s Soleno Therapeutics SLNO Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74K Sell
52
-349
-87% -$13.7K ﹤0.01% 5311
2025
Q4 		$19K Buy
401
+337
+527% +$18.5K ﹤0.01% 4210
2025
Q3 		$4K Sell
64
-1
-2% -$74 ﹤0.01% 4847
2025
Q2 		$5K Buy
65
+28
+76% +$2.1K ﹤0.01% 4639
2025
Q1 		$3K Buy
37
+8
+28% +$390 ﹤0.01% 4679
2024
Q4 		$1K Sell
29
-17
-37% -$881 ﹤0.01% 4802
2024
Q3 		$2K Buy
46
+44
+2,200% +$2.11K ﹤0.01% 4456
2024
Q2 		$0 Buy
+2
New +$85 ﹤0.01% 4908

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

Carson Wealth (CWM LLC)'s SLNO Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Soleno Therapeutics (SLNO) stake by 87% in Q1 2026, selling an estimated $13.7K and leaving 52 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #5311.

Carson Wealth (CWM LLC) first reported a position in SLNO in Q2 2024 and has held it in 8 quarters since. The position peaked at $19K in Q4 2025. 227 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Carson Wealth (CWM LLC) held 52 shares of Soleno Therapeutics worth $1.74K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 349 Soleno Therapeutics shares in Q1 2026, an estimated $13.7K.
  • Soleno Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5311 holding.
  • Carson Wealth (CWM LLC) first reported a position in Soleno Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Carson Wealth (CWM LLC)'s Soleno Therapeutics position peaked at $19K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.